๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

690 p53 and K-ras are mutated in different subtypes of bronchioloalveolar carcinoma

โœ Scribed by Marchetti, A.; Buttitta, F.; Bertacca, G.; Carnicelli, V.; Pellegrini, S.; Gaeta, P.; Filardo, A.; Chella, A.; Angeletti, C.A.; Bevilacqua, G.

Book ID
122612152
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
151 KB
Volume
18
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ra
BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE
โœ MARCHETTI, ANTONIO; BUTTITTA, FIAMMA; PELLEGRINI, SILVIA; CHELLA, ANTONIO; BERTA ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 733 KB

Bronchioloalveolar carcinoma (BAC) is a form of peripheral lung adenocarcinoma growing as a single layer of malignant cells along the walls of terminal airways. The existence of BAC as a separate clinico-pathological entity has been a matter of controversy, mainly because its histogenesis is uncerta

FHIT andp53 gene abnormalities in bronch
FHIT andp53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations
โœ Marchetti, Antonio; Pellegrini, Silvia; Bertacca, Gloria; Buttitta, Fiamma; Gaet ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB ๐Ÿ‘ 2 views

Bronchioloalveolar carcinoma (BAC) is a particular type of adenocarcinoma of the lung which accounts for up to 9 per cent of pulmonary malignancies. The aetiology and pathogenesis of this unique neoplastic disease are still unclear. Three histological subtypes of BAC have been recognized: mucinous,

Carcinogen exposure, p53 alteration, and
Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma
โœ Xi Wang; David C. Christiani; Eugene J. Mark; Heather Nelson; John K. Wiencke; L ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

BACKGROUND. Synchronous multiple primary lung tumors (SMPLT) have been estimated to occur in 1% of lung carcinoma patients. Criteria for SMPLT diagnosis include different cancer histologies, location in different lobes of the lung, or genetic discordance. Patients with SMPLT have a poor clinical pro